Featured Intelligence

The 2020 Dichotomy: An Analysis of the COVID-19 Launch Class

May 5, 2021

The challenges of the pandemic revealed an interestingly uneven response on the commercial side, prompting the question: did biopharma’s commercial innovation keep pace with the industry’s scientific progress? Some launches showed spectacular success, while others fell far short of expectations. What were the distinguishing factors that drove this dichotomy?

Read Now

Home / Intelligence

  • All
  • Briefs
  • Industry Publications
  • Scientific Publications
  • Webinars
  • Whitepaper

MedTech in the Post-COVID World: Where Do We Go From Here?

October 28, 2021 | 1:00-1:45 pm ET Trinity MedTech, a part of Trinity Life Sciences, invites you to our webinar, MedTech in the Post-COVID World: Where Do We Go From Here? We will share data from our real-world evidence team on key sectors within the broader MedTech industry to show the impact of COVID on different MedTech lines of business. We will also explore what the implications are moving forward for companies/brands. In particular, what are best practice companies/brands doing…

Watch now

Navigating the New World of Virtual Conferences

The Example of ASCO 2021 While people were expecting to return to in-person conferences soon, the emergence of the Delta variant and the possibility of future unknown variants, combined with uneven vaccination rates, has created significant uncertainty about how soon that can happen. Trinity Life Sciences wanted to understand what perceptions medical conference attendees had of the new virtual conference world, what advantages and disadvantages they saw in it, and how manufacturers performed at engaging their audiences. We performed a…

Read Now

Brand Health 2022: Steering Through the Complexity with RWE

November 16, 2021 | 1:00 pm EST In 2022, a key challenge for life sciences companies will be to identify the best ways to extract value from RWD to assess brand health for their unique context. Whether your brand is on-market already or is preparing for launch, leveraging a nuanced, evidence-based view of performance drivers — from prescriber adoption, to payer acceptance, to patient persistence – is essential to making the best decisions.  Come join RWE experts from Trinity and…

Watch now

Everything You Wanted to Know About Patient Finding but Were Afraid to Ask

According to a TGaS Advisors’ large landscape study, 45% of all machine learning commercial use cases in the life sciences industry were for finding patients, often for HCP alerts and targeting. In fact, if you are not doing patient finding alerts/targeting, you are probably behind the industry.Come join TGaS Advisors, a division of Trinity Life Sciences, as we share the “ins and outs” of patient finding, including learnings from our study. It’s clear that patient finding can have a big…

Watch now

How to Position Evidence for Successful Commercialization

The HEOR Evidence Generation team at Trinity Life Sciences will conduct a webinar to discuss recent publications geared towards crafting the value story for products prior to launch. Please join us to learn what evidence is needed and how best to position it for successful commercialization. We will present original work conducted on behalf of our valued clients in several different therapeutic areas – Oncology, Cardiology, and Rare Genetic Disorders.You already know the importance of driving awareness and conducting market…

Watch now

Agile in the Commercial Pharma Organization: Key Steps for Success

Among recent hot topics in pharma & biotech, few have been more prevalent than Agile methodologies–but what does “Agile” mean for pharma versus other industries? What are the critical Agile considerations unique to pharma, and what ad/promo, commercial operations, and compliance factors must be taken into consideration when setting up projects or pilots? During this webinar, TGaS Advisors, a division of Trinity Life Sciences, explores what commercial pharma leaders need to know when considering implementation of Agile methodologies. Driven by…

Watch now

Google’s Cookie Ban Delay Prompts Sighs of Relief, but Pharma Advertisers Shouldn’t Get Complacent

Third-party tracking cookies aren’t as important to pharma as they are to consumer marketers. Automakers, for instance, can follow online car shoppers, putting targeted digital ads in buyers’ paths as they move across the internet hoping for a sale. However, privacy policies on most sites nix drugmakers use of third-party cookies to serve ads to people looking for diabetes or cancer information. Still, tracking data does matter in pharma—especially when it comes to measurement and analytics. The good news for pharma…

Read Now

Sixty-two Percent of Biopharma Executives Say Their Organization Does Not Prioritize Diversity, Equity and Inclusion When Selecting a Vendor

Waltham, MA, July 29, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest TGaS Advisors’ report entitled Diversity, Equity, and Inclusion (DEI): An Emerging, Key Consideration When Selecting Vendors. The report finds that 62 percent of biopharma executives say their organization does not prioritize DEI as one of the top three important reasons in selecting a vendor. However, nearly half of all respondents (48 percent) indicate that DEI has increased…

Read Now

Changes in Third-Party Cookie Management and Their Effects on Pharmaceutical Brands

The elimination of third-party cookies is not a new concept. Safari and FireFox eliminated them a few years back. However, now the largest used browser (Chrome) is joining FireFox and Safari, announcing the imminent removal of third-party cookies in 2022. Organizations are attempting to navigate the impact and identify alternatives. Driven by increased user privacy, Google’s decision will require fundamental changes across media and advertising platforms. The departure of third-party cookies will change the way pharmaceutical companies, in fact all…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.